1.Köck R, et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Eurosurveillance 2010; 15: 19688.
2.Manzur A, Gudiol F. Methicillin-resistant Staphylococcus aureus in long-term-care facilities. Clinical Microbiology and Infection 2009; 15 (Suppl. 7): 26–30.
3.Manzur A, et al. Clinical significance of methicillin-resistant Staphylococcus aureus colonization in residents in community long-term-care facilities in Spain. Epidemiology and Infection 2012; 140: 400–406.
4.Daeschlein G, et al. Risk factors for Staphylococcus aureus nasal carriage in residents of three nursing homes in Germany. Journal of Hospital Infection 2006; 63: 216–220.
5.von Baum H, et al. Risk factors for methicillin-resistant Staphylococcus aureus carriage in residents of German nursing homes. Infection Control and Hospital Epidemiology 2002; 23: 511–515.
6.Woltering R, et al. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in patients in long-term care in hospitals, rehabilitation centers and nursing homes of a rural district in Germany. Deutsche Medizinische Wochenschrift 2008; 133: 999–1003.
7.Neuhaus B, et al. Survey of methicillin-resistant Staphylococcus aureus in long-term facilities for the aged in Northrhine Westphalia. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2002; 45: 898–904.
8.Suetens C, et al. Determinants of methicillin-resistant Staphylococcus aureus carriage in nursing homes. Age and Ageing 2007; 36: 327–330.
9.Pfingsten-Würzburg S, et al. Prevalence and molecular epidemiology of meticillin-resistant Staphylococcus aureus in nursing home residents in northern Germany. Journal of Hospital Infection 2011; 78: 108–112.
10.Brugnaro P, et al. Clustering and risk factors of methicillin-resistant Staphylococcus aureus carriage in two Italian long-term care facilities. Infection 2009; 37: 216–221.
11.Lasseter G, et al. Staphylococcus aureus carriage in care homes: identification of risk factors, including the role of dementia. Epidemiology and Infection 2010; 138: 686–696.
12.Vovko P, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus in a long-term-care facility in Slovenia. Infection Control and Hospital Epidemiology 2005; 26: 191–195.
13.Manzur A, et al. Prevalence of methicillin-resistant Staphylococcus aureus and factors associated with colonization among residents in community long-term-care facilities in Spain. Clinical Microbiology and Infection 2008; 14: 867–872.
14.Denis O, et al. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium. Journal of Antimicrobial Chemotherapy 2009; 64: 1299–1306.
15.Barr B, et al. Prevalence of methicillin-resistant Staphylococcus aureus colonization among older residents of care homes in the United Kingdom. Infection Control and Hospital Epidemiology 2007; 28: 853–859.
16.Eveillard M, et al. Methicillin-resistant Staphylococcus aureus carriage in a long-term care facility: hypothesis about selection and transmission. Age and Ageing 2008; 37: 294–299.
17.Oliveira DC, et al. Comparison of DNA sequencing of the protein A gene polymorphic region with other molecular typing techniques for typing two epidemiologically diverse collections of methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology 2001; 39: 574–580.
18.Koreen L, et al. spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. Journal of Clinical Microbiology 2004; 42: 792–799.
19.Baum C, et al. Non-spa-typeable clinical Staphylococcus aureus strains are naturally occurring protein A mutants. Journal of Clinical Microbiology 2009; 47: 3624–3629.
20.Enright MC, et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. Journal of Clinical Microbiology 2000; 38: 1008–1015.
21.Dulon M, et al. MRSA prevalence in European healthcare settings: a review. BMC Infectious Diseases 2011; 11: 138.
22.Ribbe MW, et al. Nursing homes in 10 nations: a comparison between countries and settings. Age and Ageing 1997; 26 (Suppl. 2): 3–12.
23.Deurenberg RH, Vink C, Kalenic S, et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clinical Microbiology and Infection 2007; 13: 222–235.
24.Wolters M, et al. MALDI-TOF MS fingerprinting allows for discrimination of major methicillin-resistant Staphylococcus aureus lineages. International Journal of Medical Microbiology 2011; 301: 64–68.
25.Schuh D. Using spa-typing to study MRSA isolated in the Grand-Duchy of Luxembourg [in French]. Liège, Belgium: Haute école Mosane d'enseignment supérieur, 2006.
26.Nubel U, et al. A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus. PLoS Pathogens 2010; 6: e1000855.
27.Grundmann H, et al. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Medicine 2010; 7: e1000215.
28.van Loo I, et al. Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerging Infectious Diseases 2007; 13: 1834–1839.
29.Waters AE, et al. Multidrug-resistant Staphylococcus aureus in US meat and poultry. Clinical Infectious Diseases 2011; 52: 1227–1230.
30.Harris SR, et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010; 327: 469–474.